Company intelligence / Profile preview

Gansu Mogao Industrial Development

Ownership: Private
Employees: ~563
Development stage: Commercial

Overview

Gansu Mogao Industrial Development is primarily a leading Chinese wine producer with additional businesses in pharmaceuticals—mainly compound licorice tablets and oral solutions—and environmentally friendly biodegradable materials. The company’s pharmaceutical segment appears limited in scope compared to its core beverage operations. No clinical trial or drug development pipeline information was found.

Modalities: Small molecule
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Gansu Mogao Industrial Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gansu Mogao Industrial Development.

Explore the full profile